Mitapivat, a novel therapeutic agent, represents a promising breakthrough in the management of erythroid disorders such as pyruvate kinase deficiency (PKD). This unique molecule functions as a potent protein kinase R, https://jadangtz910002.pointblog.net/mitapivat-a-pkr-activator-for-blood-cell-impairments-91888833